Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Study to Learn about the Study Medicine called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive Stage Sma… Pending

2025-523522-41-00 Extensive-Stage Small Cell Lung Cancer 10
Symbiotic-GU-06-A Study to Learn About the Study Medicine PF-08634404 Alone or In Combination With Enfortumab Vedotin in Adult Participants … Pending

2025-523523-21-00 Locally Advanced or Metastatic Urothelial Cancer 9
Phase I clinical trial evaluating TG4070 in patients with non-small cell lung cancer Pending

2025-520946-31-00 Non-Small Cell Lung Cancer 1
Sequential Chemotherapy regimen with vinorelbine and cisplatin plus PET-guided stereotactic ablative radiotherapy (SABR) for castration- and… Pending

2025-521551-23-01 prostate cancer 9
Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending

2025-522748-42-00 Ovarian cancer 5
A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally… Pending

2025-523524-53-00 ADVANCED OR METASTATIC RENAL CELL CARCINOMA 9
Phase II Clinical Trial of KORTUC (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer: Towards a New Organ Preservation A… Pending

2025-524378-40-00 Locally advanced high‑risk stage III rectal adenocarcin 4
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients Pending

2024-514144-85-02 Glioblastoma 3
NeoAdjuvant Dynamic marker - Adjusted Personalized Therapy comparing sacituzumab govitecan+pembrolizumab vs. SoC chemotherapy in clinical st… Pending

2024-516734-35-00 triple-negative early breast cancer 5
Symbiotic-GI-13, A Study to Learn About the Study Medicine Called PF-08634404 as Monotherapy and Combination Therapy in Adult Participants w… Pending

2025-523525-17-00 Unresectable Locally Advanced or Metastatic Hepatocellu 9
A Study to Learn about the Study Medicine called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers Pending

2025-523526-40-00 Advanced Solid Tumors 9
A randomized, open-label, Phase III trial to assess the efficacy and safety of BupiZenge compared to lidocaine for pain associated with oral… Pending

2025-524386-24-00 Head and neck cancer 5
MITO CERV4: Single arm phase II study on Pembrolizumab in pre neoplastic high grade HPV-related vulvar and cervical lesions Pending

2023-504035-40-00 Patients with pre neoplastic high grade HPV-related vul 4
A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients with Recurrent O… Pending

2024-516327-14-00 Ovarian cancer 4
Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m… Pending

2025-524408-30-01 Metastatic hormone-sensitive prostate cancer 5
A study to investigate dabogratinib (TYRA-300) in participants with Low Grade Upper Tract Urothelial Carcinoma Pending

2025-523539-20-00 Low Grade Upper Tract Urothelial Carcinoma 4
SAKK 38/19: Assessing a ctDNA and PET-oriented therapy in patients with DLBCL. A multicenter, open-label, phase II trial Pending

2024-516740-26-00 Disseminated large B-cell lymphoma 4
Staging of gastric cancers by PET-FAPI Pending

2025-524434-25-00 gastric cancer 4
AUSTRAL trial: An open-label, multicenter, phase II study of radiotherapy followed by durvalumab (MEDI4736) and ceralasertib (AZD6738) in st… Pending

2024-515942-18-01 Stage III NSCLC patients with loco-regional relapse > 1 4
A study to investigate efficacy of RP2 with nivolumab compared to ipilimumab with nivolumab in adult patients with advanced uveal melanoma n… Pending

2023-508784-68-00 metastatic uveal melanoma 10
A Phase 1/2a Study of BMS-986523 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Malignancies Pending

2025-523547-35-00 Advanced Solid Tumor Malignancies 7
Comparison of standard abiraterone dosing and dosing based on abiraterone blood levels Pending

2025-524440-35-00 metastatic castration resistant prostate cancer (mCRPC) 6
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia. Pending

2025-522138-29-00 Philadelphia positive Chronic Myeloid leukemia in Chron 4
Neo-adjuvant intraperitoneal chemotherapy (irinotecan) and systemic chemotherapy (mFOLFOX4-bevacizumab) prior to CRS-HIPEC for patients with… Pending

2024-512318-16-00 Patients with colorectal peritoneal metastases with a P 4